METFORMIN USE IS ASSOCIATED WITH DECREASED RISK OF RENAL CELL CANCER

被引：0
|
作者：
Kabarriti, Abdo
Boursi, Ben
Mamtani, Ronac
Guzzo, Thomas
Haynes, Kevin
Yang, Yu-Xiao
Malkowicz, S. Bruce
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 04期
关键词：
D O I：
10.1016/j.juro.2015.02.235
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP5-08
引用
收藏
页码：E48 / E48
页数：1
相关论文
共 50 条
  • [41] Boron is associated with decreased risk of human prostate cancer
    Zhang, ZF
    Winton, MI
    Rainey, C
    Eckhert, CD
    FASEB JOURNAL, 2001, 15 (05): : A1089 - A1089
  • [42] Young age is associated with decreased recurrence for renal cell carcinoma
    Liu, Franklin
    Davaro, Facundo
    Wong, Ryan
    Siddiqui, Sameer
    Hamilton, Zachary
    CANADIAN JOURNAL OF UROLOGY, 2022, 29 (03) : 11142 - 11149
  • [43] The use of statins in "old" randomized controlled trials was not associated with either increased or decreased risk of cancer or cancer deaths
    Gratsiansky, N. A.
    KARDIOLOGIYA, 2006, 46 (03) : 76 - 77
  • [44] Metformin is associated with decreased risk of basal cell carcinoma: A whole-population case-control study from Iceland
    Adalsteinsson, Jonas A.
    Muzumdar, Sonal
    Waldman, Reid
    Wu, Rong
    Ratner, Desiree
    Feng, Hao
    Ungar, Jonathan
    Silverberg, Jonathan, I
    Olafsdottir, Gudridur H.
    Kristjansson, Arni Kjalar
    Tryggvadottir, Laufey
    Jonasson, Jon Gunnlaugur
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (01) : 56 - 61
  • [45] METFORMIN IS ASSOCIATED WITH REDUCED RISK FOR COLORECTAL CANCER AMONG DIABETICS
    Yaseyyedi, Armaan
    Liu, Lin
    Bustamante, Ranier
    Earles, Ashley
    Gutkind, J. Silvio
    Gawron, Andrew J.
    Kaltenbach, Tonya R.
    Martinez, Maria Elena
    Gupta, Samir
    GASTROENTEROLOGY, 2018, 154 (06) : S335 - S335
  • [46] Metformin and the risk of renal cell carcinoma: a case-control analysis
    Becker, Claudia
    Jick, Susan S.
    Meier, Christoph R.
    Bodmer, Michael
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2017, 26 (03) : 257 - 262
  • [47] Duration of Metformin Use and Risk of Colon Cancer in Patients with Diabetes
    Habel, Laurel A.
    Sakoda, Lori C.
    Achacoso, Ninah S.
    Quesenberry, Charles P.
    Iodice, Christine
    Peng, Tiffany
    Erhlich, Samantha
    Ferrara, Assiamira
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 27 - 28
  • [48] Duration of Metformin Use and Risk of Prostate Cancer in Men with Diabetes
    Habel, Laurel A.
    Van Den Eeden, Stephen K.
    Sakoda, Lori C.
    Achacoso, Ninah S.
    Quesenberry, Charles P.
    Peng, Tiffany
    Ehrlich, Samantha F.
    Ferrara, Assiamira
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 170 - 170
  • [49] Association Between Metformin Use and the Risk, Prognosis of Gynecologic Cancer
    Yao, Kui
    Zheng, Heng
    Li, Tao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [50] Metformin Use in Relation With Survival Outcomes of Patients With Renal Cell Carcinoma
    Cheng, Jaryl Jun Sheng
    Li, Huihua
    Tan, Hui Shan
    Tan, Puay Hoon
    Ng, Lay Guat
    Ng, Quan Sing
    Toh, Chee Keong
    Kanesvaran, Ravindran
    Tan, Min-Han
    CLINICAL GENITOURINARY CANCER, 2016, 14 (02) : 168 - 175
12345